Stanford School of Medicine

Peptides are everywhere online, touted for looksmaxxing, muscle building, and weight loss. Stanford Medicine experts explain what is – and isn’t – backed by evidence.

Stanford researchers have discovered that tau can interfere with the tiny powerhouses inside nerve cells, potentially triggering damage linked to Alzheimer’s and related neurodegenerative disorders.

The $20 million award supports a national network of programmable cloud laboratories that could expedite research and speed innovation.

A Stanford Medicine app found that older adults’ daily travel range shrank as temperatures rose, potentially limiting social, physical, and community activity.

A molecule that increases by a thousandfold in pythons after they eat holds promise for a weight-loss drug.

Children with multiple food allergies have several treatment options – including omalizumab and oral immunotherapy – a Stanford Medicine trial has found.

Researchers at Stanford Medicine developed a tool called the Ribo-Tweezer to pluck individual components out of a mature ribosome, finding a surprising role for a protein called RACK1.

Researchers are venturing into a new area of collaboration that relies on agentic AI, co-scientists that can act independently and help humans ideate, hypothesize, and speed up scientific exploration.

In mice, a decline in how well one immune cell clears out another appears to drive aging throughout the body, a finding that could inform future treatments for age-related decline.

Stanford Medicine’s David Relman transformed clinical diagnostics and food tracing for cyclospora, the parasitic organism behind the surge of this diarrheal illness. Here’s what he thinks you should know.